MENT (Trestolone acetate) 50mg/ml

MENT (Trestolone acetate) 50mg/ml, is a synthetic anabolic-androgenic steroid (AAS) that has been studied in clinical settings for many years.

Although studies have examined MENT for use in testosterone replacement therapy and male hormonal contraception, MENT—first synthesized in 1963—remains an experimental substance that has never received medical approval.

Trestolone acetate, also known by its acronym MENT (7α-methyl-19-nortestosterone), is a synthetic anabolic-androgenic steroid (AAS) that has undergone clinical study for many years.

MENT is a promising option for male hormonal contraception due to its strong antigonadotropic qualities. Clinical studies have shown that MENT treatment can provide sufficient androgenic replacement to sustain male physiological processes, including as desire and sexual health, while also producing reversible reduction of sperm production.

Furthermore, MENT has been studied for hypogonadal men undergoing androgen replacement treatment. One characteristic that sets MENT apart from many other AAS chemicals is that it seems to be able to sustain normal male physiology even in the total absence of natural testosterone.

Even though MENT has medicinal potential, there are serious safety concerns. Because MENT is an aromatizable substance, it can convert to estrogenic metabolites, which may result in negative consequences associated with estrogen, such as hypertension, gynecomastia, and water retention Additionally, MENT significantly inhibits the production of natural testosterone, just like all powerful AAS drugs, necessitating careful management of hormonal recovery after withdrawal. The compound’s long-term safety profile is still unknown, and it has never finished the clinical testing process necessary for regulatory approval.